Eradivir $10.25M Series A funding round Two Eradivir employees conduct research on the company’s EV25 influenza therapeutic.

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Huadong Medicine Co. Ltd. recently revealed data from in vitro and preclinical studies performed to evaluate the efficacy and pharmacokinetic, safety and tolerability profiles of a dual glucagon-like ...

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

Rakuten Medical Inc. has presented preclinical results with RM-0256, a PD-L1-targeted photoimmunotherapy, showing its ability ...

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given researchers a deeper insight into how prostate cancer spreads or metastasizes.

Researchers at Duke-NUS Medical School have discovered that interleukin-11 (IL11) plays a crucial role in the aging process, ...

Two new therapies have successfully cleared tau aggregates in preclinical and mouse models, showing potential as dementia ...

Late-breaking oral presentation will discuss the potential of ZL-1503 as a novel treatment for moderate-to-severe atopic ...

A biomarker of eight microRNAs forms a "fingerprint" of ALS in the blood, which can be detected with 98% accuracy in a ...

The option gives Glaukos exclusive global license agreements on pre-agreed terms, including upfront and milestone payments ...